Skip to content

    Fairchem Organic

    FAIRCHEMOR
    Chemicals·13 Aug 2025
    Management Summary

    Fairchem Organics reported a sequential improvement in Q1 FY26, with revenue growing 8.5% QoQ to INR 131 crores and PAT doubling to INR 1.2 crores, driven by volume growth and power/fuel cost savings. However, the company continues to face challenges from high raw material prices and Chinese dumping in the Dimer Acid market, leading to a 21% YoY revenue decline. Management is optimistic about value growth from isostearic acid and positive trials for a lower-cost alternative raw material, with a decision expected by November.

    Highlights

    5
    • Revenue from operations increased by 8.5% quarter-on-quarter to INR 131 crores.

    • EBITDA margin improved to 3.97% from 3.64% in the previous quarter.

    • Net profit after tax doubled sequentially to approximately INR 1.2 crores.

    • Revenue growth was primarily driven by 7.5% growth in volumes.

    • Initial trial runs for an alternative raw material to reduce import dependence have been positive, with potential for lower costs.

    Concerns

    4
    • Revenue decreased 21% year-on-year.

    • The Dimer Acid market continues to face pressure due to aggressive price competition from Chinese suppliers and high raw material costs.

    • Raw material prices remain largely firm due to elevated global vegetable oil prices, despite a partial rollback of additional custom duties.

    • The customer validation process for the value-added isostearic acid product is taking longer than expected.

    What Changed2

    vs Q2 FY26

    Guidance items4 → 2 (-2)Risks discussed7 → 4 (-3)

    Key financials

    Single quarter

    10 metrics
    1. 01Revenue from Operations₹131 Cr-21%YoY
    2. 02EBITDA₹5 Cr
    3. 03EBITDA Margin4.0%+9.1%QoQ
    4. 04Net Profit After Tax₹1.2 Cr+100%QoQ
    5. 05Volume Growth7.5%

    Guidance & targets

    2
    CategoryTargetPriority
    Volume
    Isostearic Acid Export Volumes
    increase gradually
    Low
    New Product Development
    Alternative Raw Material Commercialization Decision
    decision by November
    Medium

    Alternative Raw Material Commercialization Decision

    By November (Q3 FY26)
    CurrentInitial trial runs positive
    TargetDecision on commercialization

    Why it matters

    Potential for lower raw material costs and improved spreads, crucial for margin recovery.

    Initial trial runs have been positive. And after some more runs, we will decide to go on commercial or not. So, maybe by November, we'll be through with the whole thing.

    How to verify

    detailed_narrative[title='Alternative Raw Material Development']

    Risks & concerns

    4
    RiskSeverity

    Chinese Dumping and Price Competition

    Aggressive price competition from Chinese suppliers in the Dimer Acid market, leading to a 20% price drop in 24 months.Management acknowledged

    high

    High Raw Material Costs

    Raw material prices remain largely firm due to elevated global vegetable oil prices, partially offsetting margin improvements.Management acknowledged

    high

    Regulatory Duties and Import Tariffs

    A net impact of 11% duty still remains after partial rollback, impacting cost structure, and future business could be affected by U.S. tariffs on isostearic acid.Management acknowledged

    high

    Isostearic Acid Customer Validation Delays

    The customer validation process for isostearic acid is taking longer than expected as an Indian company builds trust in a market dominated by European/American players.Management acknowledged

    medium

    Q&A highlights

    7

    “Yes. The additional duty was levied in September, and we made the representation to government in November 2024. But I think as we are the only manufacturer of dimer fatty acids in India. Maybe being a single manufacturer, it might be for them also to take call would be a tough thing. No, not in short term.”

    Highlights the ongoing challenge from Chinese dumping and high raw material costs, with limited short-term government relief expected.

    asked by Aashish from InvesQ PMS

    2 min read6 chapters

    Detailed Narrative

    01

    Q1 FY26 Financial Performance Overview

    Fairchem Organics reported a revenue from operations of INR 131 crores for Q1 FY26, marking an 8.5% increase quarter-on-quarter but a 21% decrease year-on-year. EBITDA stood at approximately INR 5 crores, with the EBITDA margin improving slightly to 3.97% from 3.64% in the previous quarter. The company achieved a net profit after tax of approximately INR 1.2 crores, which doubled sequentially, primarily driven by a 7.5% growth in volumes and savings in power and fuel costs.

    02

    Raw Material and Duty Impact

    The company continues to face challenges from high raw material prices, which remain firm due to elevated global vegetable oil prices. Despite a partial rollback of additional custom duties in May, the net impact of an 11% duty still remains, affecting the cost structure. The basic custom duty on imported dimer acid is 7.5%, and the differential on raw material due to vegetable oil duty hikes is 22.5%. Management noted that the duty rollback has not positively impacted raw material prices.

    03

    Dimer Acid Market Challenges

    The Dimer Acid market segment is under significant pressure due to aggressive price competition from Chinese suppliers and insufficient relief in raw material costs. Management highlighted that the rolling dimer acid price has dropped by approximately 20% over the last 24 months, from INR 180,000 per metric ton to less than INR 145,000 per ton. The company has made representations to the government regarding dumping but expects no short-term relief.

    04

    Isostearic Acid Market Expansion

    Isostearic acid is identified as a key value-added product with promising growth prospects, and the company is one of only three global manufacturers. Fairchem's current capacity for isostearic acid is estimated to be 10-15% of the total world demand. However, the customer validation process for this product, particularly for cosmetics applications, is taking longer than expected as the company, being an Indian entrant, works to build trust in the market. Export volumes are expected to increase gradually over the coming quarters, with sales already made to more than 7-8 countries.

    05

    Alternative Raw Material Development

    Fairchem Organics is actively working on developing an alternative raw material to reduce its dependence on imports and improve spreads. Initial trial runs for this new raw material have been positive, and management anticipates making a decision on commercialization by November. This initiative is expected to offer lower costs compared to current raw materials, providing a positive sign to address the ongoing duty and raw material price challenges.

    06

    Capacity and Product Mix

    The company's total installed raw material throughput capacity is 120,000 metric tons per annum. Of this, 40,000 metric tons are earmarked for new raw materials and finished products currently under developmental work, leaving 80,000 metric tons for existing products. The current capacity utilization stands at approximately 70% for the reported revenue levels. The sales mix for prime products (dimer acid, linoleic acid, and isostearic acid) remains between 70% and 75% of total sales value, with linoleic acid contributing around 40%, dimer acid 24-25%, and isostearic acid 6-7%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.